Hepatitis C: Is eradication possible?
来源期刊:Liver InternationalDOI:10.1111/liv.14011
Diagnostic and prognostic biomarkers in cholangiocarcinoma
来源期刊:Liver InternationalDOI:10.1111/liv.14090
Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States
来源期刊:Liver InternationalDOI:10.1111/liv.14054
Prevalence and outcomes of non‐alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States
来源期刊:Liver InternationalDOI:10.1111/liv.14038
Fatigue in chronic liver disease: New insights and therapeutic approaches
来源期刊:Liver InternationalDOI:10.1111/liv.13919
Autoimmune hepatitis: Current and future therapeutic options
来源期刊:Liver InternationalDOI:10.1111/liv.14062
Hepatitis B virus infection and risk of non‐alcoholic fatty liver disease: A population‐based cohort study
来源期刊:Liver InternationalDOI:10.1111/liv.13933
Autoimmune hepatitis exerts a profound, negative effect on health‐related quality of life: A prospective, single‐centre study
来源期刊:Liver InternationalDOI:10.1111/liv.13960
Non‐alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle‐aged adults: The Framingham Study
来源期刊:Liver InternationalDOI:10.1111/liv.14161
Clinicopathological features of He Shou Wu‐induced liver injury: This ancient anti‐aging therapy is not liver‐friendly
来源期刊:Liver InternationalDOI:10.1111/liv.13939
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma
来源期刊:Liver InternationalDOI:10.1111/liv.14094
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study
来源期刊:Liver InternationalDOI:10.1111/liv.14154
Pathways of hepatic and renal damage through non‐classical activation of the renin‐angiotensin system in chronic liver disease
来源期刊:Liver InternationalDOI:10.1111/liv.14272
Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
来源期刊:Liver InternationalDOI:10.1111/liv.14070
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
来源期刊:Liver InternationalDOI:10.1111/liv.14270
Incidence, predictors and prognosis of genotype 4 hepatitis E related liver failure: A tertiary nested case‐control study
来源期刊:Liver InternationalDOI:10.1111/liv.14221
Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis
来源期刊:Liver InternationalDOI:10.1111/liv.14125
Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono‐infection
来源期刊:Liver InternationalDOI:10.1111/liv.14000
Long‐term outcomes of patients with hepatitis B virus‐related acute on chronic liver failure: An observational cohort study
来源期刊:Liver InternationalDOI:10.1111/liv.14072
P57‐mediated autophagy promotes the efficacy of EGFR inhibitors in hepatocellular carcinoma
来源期刊:Liver InternationalDOI:10.1111/liv.13957
Role of oestrogen and its receptors in HEV‐associated feto‐maternal outcomes
来源期刊:Liver InternationalDOI:10.1111/liv.13928
HCV reinfections after viral clearance among HIV‐positive patients with recent HCV infection in Taiwan
来源期刊:Liver InternationalDOI:10.1111/liv.14199
Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug‐induced liver injury from autoimmune hepatitis
来源期刊:Liver InternationalDOI:10.1111/liv.14195
Prognostic impact of neutrophil‐to‐lymphocyte ratio in cirrhosis: A propensity score matching analysis with a prespecified cut‐point
来源期刊:Liver InternationalDOI:10.1111/liv.14211
miR‐4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation
来源期刊:Liver InternationalDOI:10.1111/liv.14276
Deficiency of canonical Wnt/β‐catenin signalling in hepatic dendritic cells triggers autoimmune hepatitis
来源期刊:Liver InternationalDOI:10.1111/liv.14246
Longitudinal analysis of risk of non‐alcoholic fatty liver disease in adulthood
来源期刊:Liver InternationalDOI:10.1111/liv.13993
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs
来源期刊:Liver InternationalDOI:10.1111/liv.14186
Ideal cardiovascular health metrics and the risk of non‐alcoholic fatty liver disease: A cross‐sectional study in northern China
来源期刊:Liver InternationalDOI:10.1111/liv.14060
Low prevalence of occult hepatitis B virus infection in chronic haemodialysis and kidney transplant patients
来源期刊:Liver InternationalDOI:10.1111/liv.13951
Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult‐to‐manage hydrothorax in cirrhosis
来源期刊:Liver InternationalDOI:10.1111/liv.14200
Dietary fatty acid oxidation is decreased in non‐alcoholic fatty liver disease: A palmitate breath test study
来源期刊:Liver InternationalDOI:10.1111/liv.14309
Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study
来源期刊:Liver InternationalDOI:10.1111/liv.13963
Effect of direct‐acting antivirals on platelet‐associated immunoglobulin G and thrombocytopenia in hepatitis C virus‐related chronic liver disease
来源期刊:Liver InternationalDOI:10.1111/liv.14120
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir
来源期刊:Liver InternationalDOI:10.1111/liv.14017
Adherence to pan‐genotypic glecaprevir/pibrentasvir and efficacy in HCV‐infected patients: A pooled analysis of clinical trials
来源期刊:Liver InternationalDOI:10.1111/liv.14266
Long‐term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country
来源期刊:Liver InternationalDOI:10.1111/liv.14082
Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient
来源期刊:Liver InternationalDOI:10.1111/liv.14273
Long‐term outcomes of endoscopic treatment for duct‐to‐duct anastomotic strictures after living donor liver transplantation
来源期刊:Liver InternationalDOI:10.1111/liv.14219
Tolerability and effectiveness of generic direct‐acting antiviral drugs in eradication of hepatitis C genotype 4 among Egyptian patients
来源期刊:Liver InternationalDOI:10.1111/liv.14022
The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg‐negative chronic hepatitis B
来源期刊:Liver InternationalDOI:10.1111/liv.14330
Prognostic assessment using a new substaging system for Barcelona clinic liver cancer stage C hepatocellular carcinoma: A nationwide study
来源期刊:Liver InternationalDOI:10.1111/liv.14117
microRNA‐206 modulates the hepatic expression of the organic anion‐transporting polypeptide 1B1
来源期刊:Liver InternationalDOI:10.1111/liv.14212
Comments on ‘Entecavir resistance mutations rtL180M/T184L/M204V combined with rtA200V lead to tenofovir resistance’
来源期刊:Liver InternationalDOI:10.1111/liv.14290
A genome‐wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study)
来源期刊:Liver InternationalDOI:10.1111/liv.14177
[18F]‐Fluoro‐2‐deoxy‐D‐galactose positron emission tomography/computed tomography as complementary imaging tool in patients with hepatocellular carcinoma
来源期刊:Liver InternationalDOI:10.1111/liv.14293
Longitudinal studies can identify distinct inflammatory cytokines associated with the inhibition or progression of liver cancer
来源期刊:Liver InternationalDOI:10.1111/liv.14323
Injury pattern recognition to discriminate competing causes of liver injury
来源期刊:Liver InternationalDOI:10.1111/liv.14056
Cytocholestasis and Hypercalcemia ‐ what’s the connection?
来源期刊:Liver InternationalDOI:10.1111/liv.14158
Reply to Mantovani: “Causality between non‐alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes”
来源期刊:Liver InternationalDOI:10.1111/liv.14026